People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Streamline, Inc. | — | Other Health Care | Pre-Seed | $1.5M | $14.7M | 2011 |
| TeVido BioDevices, Inc. | — | Biotechnology | Seed | $1.4M | $63.1M | 2019 |
Rick Schultz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rick Schultz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jim Phillips | 1 | 4 |
| John Blank | 1 | 2 |
| James Albrecht | 1 | 2 |
| PETER BLANKENSHIP | 1 | 2 |
| Patrick Kullmann | 1 | 2 |
| RYAN DOUGLAS | 1 | 2 |
| Laura Bosworth | 1 | 1 |
| Dustin Thompson | 1 | 1 |
| Samuel Blankenship | 1 | 1 |
| Jerry Nye | 1 | 1 |
| Tom Vollmer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.